When was China Medical System founded?

China Medical System was founded in 1992.

Where is China Medical System located?

China Medical System is headquartered in Shenzhen, China.

Who is the current CEO of China Medical System?

Lam Kong of China Medical System. They have also founded 1 company.

How many employees does China Medical System have?

As of Aug 31, 2026, the latest employee count at China Medical System is 295.

Where does China Medical System rank among its competitors?

China Medical System ranks 8th amongst 1100 active competitors, of which 71 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Caidya, which secured $165M in Jan, 2025.

Who are the top competitors of China Medical System?

China Medical System's top competitors include WuXi AppTec, Precision Medicine Group and ANI Pharmaceuticals. Among them, Caidya secured the most recent funding round in January, 2025.

China Medical System - 2026 Company Profile, Team, Funding & Competitors

Company Details

China Medical System manufactures generic formulations. They offer tablets, capsules, liquids, and injectables. The products are of various therapeutic categories including cardiovascular, respiratory, oncology, analgesics, CNS, etc. They have also pipeline products. Their lead molecule FP-1201 is used for Acute Respiratory Distress Syndrome, which is in phase III clinical trial.

Website: web.cms.net.cn/zh/home/
Email ID: *****@cms.net.cn
Phone Number: +86 **********

Key Metrics

Founded Year

1992

Location

Shenzhen, China

Stage

Public

Investors

CMS Ventures

Ranked

8^th among 1100 active competitors

Employee Count

295 as on Aug 31, 2026

Investment & Acquisitions

Beyangtx & 4 more

Similar Companies

WuXi AppTec & 1144 more

Exit Details

Public

View China Medical System's full profile

China Medical System got listed on Sep 28, 2010.

Click here to take a look at China Medical System's IPO in detail

China Medical System is a funded company. China Medical System has 1 institutional investor.

View details of China Medical System's funding rounds and investors

The founders of China Medical System is Lam Kong. Lam Kong is the CEO of China Medical System.

Here are the details of China Medical System's key team members:

Lam Kong: Founder & CEO & Chairman & President of China Medical System.

View details of China Medical System's Founder profiles and Board Members

China Medical System's employee count trend

China Medical System has 295 employees as of Aug 26. Here is China Medical System's employee count trend over the years:

Employee count trend for China Medical System

Uncover China Medical System's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of China Medical System include WuXi AppTec, Precision Medicine Group and ANI Pharmaceuticals. Here is the list of Top 10 competitors of China Medical System, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	WuXi AppTec 2000, Shanghai (China), Public	Provider of CRO and CDMO services	$40M	Synergis Capital, HongShan & 27 others	75/100
2nd	Precision Medicine Group 2012, Bethesda (United States), Late Stage	Provider of clinical research, development, and commercialization services for life sciences	$532M	TPG, Oak Investment Partners & 7 others	72/100
3rd	ANI Pharmaceuticals 1996, Baudette (United States), Public	Manufacturer of pharmaceutical products, including extended-release capsules and immediate-release tablets	-	JPMorgan Chase, Ampersand Capital & 4 others	64/100
4th	Ipsen 1929, Paris (France), Public	Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes	-	Digital Pharma Lab, PAI Partners & 2 others	63/100
5th	Zuellig Pharma 1992, Singapore (Singapore), Funding Raised	Provider of clinical research, quality management, logistics, and clinical trial supply services	-	Temasek	61/100
6th	Eurofins Scientific 1987, Luxembourg (Luxembourg), Public	Provider of laboratory testing services and CRO contract research services	-	CDPQ, Holland Capital & 1 others	61/100
7th	EVERSANA 2014, Milwaukee (United States), Funding Raised	Provider of consulting services for drug pricing access, reimbursement, and regulatory support	-	North Sky Capital, Pantheon International ... & 3 others	57/100
8th	China Medical System 1992, Shenzhen (China), Public	Manufacturer of generic formulations	-	CMS Ventures	55/100
9th	Caidya 2003, Morrisville (United States), Series C	CRO focused on clinical development for phases II & III clinical trials and regulatory affair services	$373M	Qiming Venture Partners, Fidelity Investments ... & 22 others	54/100
10th	Red Nucleus 2014, Yardley (United States), Acquired	Provider of advisory, scientific and medical communications for pharmaceutical industry	-	Maranon Capital, Renovus Capital Partners	52/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on China Medical System's competitors? Click here to see the top ones

China Medical System has made 4 investments in companies including Beyangtx and N1 Life. China Medical System has also acquired 1 companies including Luqa Pharma.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Aug 12, 2026	Investments	Beyangtx		-
Apr 17, 2023	Investments	N1 Life	2019	Milpitas (United States)
Sep 15, 2022	Investments	EYE TECH CARE	2008	Lyon (France)

Want to know more about where corporates are investing? Sign up today!

See all investments by China Medical System

Here is the latest report on China Medical System's sector:

Free

Biopharma Outsourcing - Sector Report

Edition: July, 2026 (67 Pages)

View all reports related to China Medical System

Media has covered China Medical System for a total of 17 events in the last 1 year, 5 of them have been about company updates and 1 about partnerships.